In future investigation protocols for LS it may be feasible to have a hypermethylation test done on MLH1 deficient tumors to exclude them for germline testing as long as those patients do not have a strong family history for LS which our MSH2 carrier had. This evidence concerns the gene MSH2 and Leigh syndrome.